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Impaired aquaporin and urea transporter expression in rats with
adriamycin-induced nephrotic syndrome. Nephrotic syndrome is associ-
ated with abnormal regulation of renal water excretion. To investigate the
role of collecting duct water channels and solute transporters in this
process, we have carried out semiquantitative immunoblotting of kidney
tissues from rats with adriamycin-induced nephrotic syndrome. These
experiments demonstrated that adriamycin-induced nephrotic syndrome is
associated with marked decreases in expression of aquaporin-2, aqua-
porin-3, aquaporin-4, and the vasopressin-regulated urea transporter in
renal inner medulla, indicative of a suppression of the capacity for water
and urea absorption by the inner medullary collecting duct. In contrast,
expression of the a1-subunit of the Na,K-ATPase in the inner medulla was
unaltered. Light and electron microscopy of perfusion-fixed kidneys
demonstrated that the collecting ducts are morphologically normal and
unobstructed. Inner medullary expression of the descending limb water
channel, aquaporin-1, was not significantly altered, pointing to a selective
effect on the collecting duct. Aquaporin-2 and aquaporin-3 expression was
also markedly diminished in the renal cortex, indicating that the effect is
not limited to the inner medullary collecting duct. Differential centrifu-
gation studies and immunocytochemistry in inner medullary thin sections
demonstrated increased targeting of aquaporin-2 to the plasma mem-
brane, consistent with the expected short-term action of vasopressin on
aquaporin-2 trafficking. The extensive down-regulation of aquaporin and
urea transporter expression may represent an appropriate renal response
to the extracellular volume expansion observed in nephrotic syndrome, but
may occur at the expense of decreased urinary concentrating and diluting
capacity.
The kidney plays a central role in the regulation of body salt and
water balance. Disordered regulation of transport in the kidney is
responsible for altered salt and water balance in several patho-
physiological states including the nephrotic syndrome. Regulation
of salt and water excretion depends on an array of solute and
water transporters in renal tubules and vascular elements in the
various regions of the kidney [1]. Recent progress in cloning of
cDNAs for many of these transporters has made it possible to
prepare specific antibodies that can be used to investigate physi-
ological and pathophysiological mechanisms [2]. Using these
antibodies, several transporter proteins important for the regula-
tion of water excretion have recently been characterized. One
example is the vasopressin-regulated urea transporter, which
mediates the exit of urea from the inner medullary collecting duct,
a process that is critical for the accumulation of urea in the inner
medullary interstitium and the generation of a corticomedullary
osmolality gradient [3]. Also important in the regulation of renal
water excretion are the aquaporin water channels. Aquaporins are
a newly recognized family of transmembrane proteins that func-
tion as molecular water channels [4]. Four aquaporins (aqua-
porin-1, -2, -3 and -4) are known to be expressed in the kidney
where they mediate osmotic water transport across water-perme-
able epithelia and play critical roles in the concentrating and
diluting process. Aquaporin-1 is expressed in the proximal tubule
and descending limb of Henle’s loop, while aquaporin-2, -3 and -4
are expressed in the collecting duct system.
Aquaporin-2 is recognized as the “vasopressin-regulated water
channel.” Vasopressin regulates aquaporin-2 in two ways. It has a
short-term effect to trigger translocation of aquaporin-2-contain-
ing intracellular vesicles to the apical plasma membrane, thus
increasing principal cell water permeability [5–7]. In addition,
vasopressin has a long-term effect to increase the abundance of
aquaporin-2 in collecting duct principal cells, increasing the
maximally attainable water permeability [8–10]. Furthermore,
long term antidiuresis is associated with increased abundance of
the basolateral water channel aquaporin-3 [10, 11].
Several diseases characterized by extracellular fluid volume
expansion are associated with excessive renal salt and water
reabsorption, such as congestive heart failure, hepatic cirrhosis,
and nephrotic syndrome. The mechanisms of salt and water
retention in these process are incompletely understood, but can
be expected to be associated in part with abnormal regulation of
renal solute and water transporters. For example, it has been
demonstrated in congestive heart failure rats with hyponatremia
that the abundance of aquaporin-2 is markedly increased, provid-
ing a probable explanation for the excess of free water reabsorp-
tion in this state [12, 13]. Furthermore, rat models of hepatic
cirrhosis have suggested a similar picture with an increase in
aquaporin-2 expression in the kidney [14, 15]. In contrast, a
completely different picture has been observed with a rat model of
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nephrotic syndrome [16]. Specifically, puromycin aminonucleo-
side (PAN)-induced nephrotic syndrome in rats was found to be
associated with a marked decrease in the expression of aqua-
porin-2 and aquaporin-3 in the inner medulla, which could be
considered a physiologically appropriate kidney response to sys-
temic water retention. Although this study provided new data
important to the understanding of the pathophysiology of ne-
phrotic syndrome, several questions remain to be addressed.
The present study had several objectives. First, we wished to
investigate whether the decrease in aquaporin expression in the
inner medulla seen previously in PAN-nephrotic syndrome is
unique to PAN model or could be a more general characteristic of
the nephrotic syndrome. To address this question we set up a
different model of nephrotic syndrome, namely, the adriamycin-
induced nephrotic syndrome [17]. Second, to address whether the
down-regulation of aquaporin expression is unique to the medul-
lary portion of the collecting duct, we investigated the expression
of water channels in both cortex and medulla. Third, we investi-
gated whether the suppression of transporter expression was
limited to water channels or includes collecting duct solute
transporters.
METHODS
Antibodies
Polyclonal antibodies prepared against aquaporin-1 [10], aqua-
porin-2 [9], aquaporin-3 [11], aquaporin-4 [18], and vasopressin-
regulated urea transporter [3] have been described previously.
They were raised against carrier-conjugated synthetic peptides
corresponding to the carboxyl terminal tails of each of the
proteins. The specificity of each has been demonstrated by
showing unique peptide-abatable bands on immunoblots and a
unique distribution of labeling by immunohistochemistry and
immunoelectron microscopy. All of these antibodies were affinity
purified against the immunizing peptides for use in these studies.
Antibodies against the heterotrimeric G-protein subunit Gsa
[19] and the adenylyl cyclase isotype VI (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA) were also used. In addition, mouse
monoclonal antibodies against the Na,K-ATPase a1 subunit
(Upstate Biotechnology, Lake Placid, NY, USA) and against the
heat shock protein Hsp-70 (Stressgen, Victoria, B.C., Canada)
were employed.
Animal model
Pathogen-free male Sprague-Dawley rats (National Cancer
Institute Breeding Facility, Frederick, MD, USA; body wt 200 to
300 g) were used in this study. These rats were maintained initially
in filter-top microisolator cages with autoclaved food and bedding,
and were allowed free access to drinking water all the times. After
equilibration in metabolism cages, the animals were briefly anes-
thetized by inhalation of Metofane and were injected intrave-
nously through the femoral vein adriamycin with 7.5 mg/kg weight
(doxorubicin hydrochloride; Sigma, St. Louis, MO, USA) dis-
solved in sterile normal saline, or were injected with the vehicle
alone. The rats were subsequently maintained in the metabolism
cages to allow urine collections. Three set of animals were studied,
two for immunochemical approaches and the other one for
morphological analysis.
The animals were killed by decapitation and blood was col-
lected from the neck. Serum was separated and saved at 220°C
for analysis. The urine voided over the 12 hours period immedi-
ately preceding death of the animals was also collected and saved
for analysis.
All animal experimentation described in this article was con-
ducted in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals (NHLBI/IR protocol
number 5-KE-1).
Blood and urine analysis
Urine and serum osmolalities were measured using a vapor
pressure osmometer (Model 5100C; Wescor, Logan, UT, USA).
Urine and serum proteins were measured by using bicinchoninic
acid (BCA) protein assay reagent (Pierce, Rockford, IL, USA).
Serum cholesterol and triglycerides were measurement by enzy-
matic reaction (Kits 352-20 and 330-10, respectively; Sigma).
Urine and serum sodium were also determined by flame photom-
etry. Creatinine levels in urine and serum samples were quantified
colorimetrically (alkaline picrate method, Kit no. 555-A; Sigma
Diagnostics). The clearance of creatinine (CCr) was determined
by the formula CCr 5 V 3 (U/P)Cr, where V is the volume flow of
urine (ml/min) voided in a given collection and (U/P)Cr is the ratio
of the concentration of creatinine in urine to that in serum. In
addition, intraperitoneal fluid volume was quantified in each rat
by collecting the fluid into pre-weighed 50 ml centrifuge tubes and
reweighing the tubes. The samples were collected by aspiration
from the opened peritoneal cavity with a syringe followed by
adsorption of the remaining fluid with gauze sponges. The
sponges were included in the centrifuge tubes when they were
preweighed so that the difference in weight represented the
weight of the collected peritoneal fluid. Peritoneal fluid volumes
in ml were then calculated assuming that the intraperitoneal fluid
has a density of 1.0.
Kidney dissection and tissue preparation for immunoblotting
After killing the rats, both kidneys were rapidly removed and
washed briefly in isotonic saline. The left kidneys were dissected
to obtain inner medulla and cortex. The tissue was initially
homogenized for 15 seconds using a tissue homogenizer (Omni
1000 fitted with a micro-sawtooth generator) in ice-cold isolation
solution containing 250 mM sucrose/10 mM triethanolamine (Cal-
biochem, La Jolla, CA, USA) with 1 mg/ml leupeptin (Bachem
California, Torrance, CA, USA) and 0.1 mg/ml phenylmethyl
sulfonyl fluoride (United States Biochemical Corporation, To-
ledo, OH, USA). The total protein concentration in each sample
was measured using the Pierce BCA protein assay reagent kit.
The right kidneys were homogenized and differential centrifu-
gation was carried out as follows. The whole kidney homogenate
from the right kidneys were centrifuged at 1000 3 g for ten
minutes to remove nuclei and incompletely homogenized mem-
brane fragments. To increase yield, this pellet was rehomogenized
as described above and was spun again at 1000 3 g for 10 minutes.
The supernatants from the two 1000 3 g centrifugations were
pooled to give the “post-nuclear supernatant.” The post-nuclear
supernatant was subjected to two subsequent centrifugations. To
obtain a plasma membrane-enriched fraction [20], the pooled
supernatant was centrifuged at 17,000 3 g for 20 minutes. Then,
the supernatant from the 17,000 3 g centrifugation was spun to
200,000 3 g for 60 minutes to obtain a vesicle-enriched fraction
[20]. The 1000 3 g and 17,000 3 g centrifugations were carried
out using a Sorvall RC2-B refrigerated centrifuge with a SS-34
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rotor (DuPont Medical Products, Newtown, CT, USA). The
200,000 3 g spin was carried out with a Beckman L8-M ultracen-
trifuge fitted with a type 80TI rotor. The resulting pellets were
resuspended in isolation solution and total protein concentration
in membrane fraction was measured using the Pierce BCA
Protein Assay reagent kit prior to addition of Laemmli sample
buffer for immunoblotting.
Electrophoresis and immunoblotting of membrane proteins
The membranes were solubilized at 60°C for 15 minutes in
Laemmli sample buffer. Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis was performed on 6% or 12% polyacrylamide.
For each set of samples from vehicle treated control rats and
adriamycin-treated rats, an initial gel was stained with Coomassie
blue to confirm that equal loading had been achieved as described
previously [10]. Representative bands were quantified by laser
densitometry (Personal Densitometer SI; Molecular Dynamics,
San Jose, CA, USA), assuring that loading did not differ for any
sample by more than 10% from the mean. For immunoblotting,
the proteins were transferred from unstained gels electrophoreti-
cally to nitrocellulose membranes. After being blocked with 5 g/dl
nonfat dry milk for 30 minutes, the blots were probed with the
respective antibodies, for 24 hours at 4°C. After washing, the
nitrocellulose membranes were exposed to secondary antibody
(donkey anti-rabbit immunoglobulin G conjugated with horserad-
ish peroxidase, Pierce no. 31458, diluted 1:5000, or goat anti-
mouse IgG conjugated with horseradish peroxidase, Pierce no.
31434, diluted 1:5000) for one hour at room temperature. Sites of
antibody-antigen reaction were visualized using luminol-based
enhanced chemiluminescence (Supersignal Substrate for Western
blotting, Pierce no. 34080). The blots were quantitated by densi-
tometry (Molecular Dynamics Model PDS1-P90 with Image-
QuaNT v4.2 software).
Electron microscopy of renal tissue
The kidneys from control and adriamycin-treated rats were
preserved for transmission electron microscopy by vascular per-
fusion fixation. The rats were anesthetized with Inactin (Thiobut-
albarbital, 100 mg/kg body wt, intraperitoneally) and a laparotomy
was performed. The abdominal aorta was cannulated below the
renal arteries and, after the vena cava was severed, a physiological
saline solution (37°C) was perfused though the kidney at a
pressure of 140 mm Hg. After the kidneys were cleared of blood
and without interruption of perfusion pressure, a phosphate-
buffered 2% glutaraldehyde solution (pH 7.2, 410 mOsm) was
perfused through the kidneys for approximately three minutes.
Following perfusion fixation, the samples were immersed in
phosphate-buffered 2% glutaraldehyde overnight. For electron
microscopy, the fixed kidneys were cut into small blocks, postfixed
in 2% osmium tetroxide for one hour, stained in 2% aqueous
uranyl acetate for three hours at room temperature, dehydrated
through graded acetones and embedded in Spurr medium. Ultra-
thin sections (50 to 80 nm) were post-stained with uranyl acetate
and lead citrate and viewed in JEOL 1200 EX electron micro-
scope (JEOL U.S.A., Peadody, MA) operating at 60 or 80 kV.
Immunocytochemistry
Kidneys from adriamycin-treated and control rats were fixed by
vascular perfusion through the abdominal aorta as described
above except that the fixative was 4% paraformaldehyde in 0.1 M
sodium cacodylate buffer, pH 7.2. The kidneys were post-fixed in
the same solution for two hours and then stored in 0.1 M
cacodylate buffer, pH 7.2 at 4°C. Tissue blocks were prepared
from cortex, outer medulla and from different levels of the inner
medulla. The blocks were infiltrated for 30 minutes with 2.3 M
sucrose containing 2% paraformaldehyde, mounted on holders
and rapidly frozen in liquid nitrogen, essentially as described
previously [8]. The frozen tissue blocks were cryosectioned for
immunohistochemistry.
Affinity-purified polyclonal anti-aquaporin-2 (L127) was used
at 0.1 to 0.3 mg/ml. Cryosections of thickness approximately 0.8
mm were obtained with a Reichert Ultracut S Cryo-ultramic-
rotome and were placed on gelatin-coated glass slides. After
preincubation with phosphate-buffered saline (PBS) containing
1% bovine serum albumin (BSA) or 0.1% skimmed milk and 0.05
M glycine for five minutes, the sections were incubated overnight
at 4°C with the primary antibody diluted in PBS with 0.1% BSA or
0.1% skimmed milk.
The labeling was visualized by incubation for one hour at room
temperature with HRP-conjugated secondary antibody (P448
1:100; DAKO, Glostrup, Denmark), followed by incubation with
diaminobenzidine for 10 minutes. Sections were counterstained
with Meier counterstain. The following controls were performed:
(1) The primary antibody was substituted with non-immune rabbit
IgG purified on a protein A column. (2) Adsorption controls
carried out by incubation with affinity purified anti-aquaporin-2
previously reacted with the immunizing peptide. (3) Incubations
were carried out without use of primary antibody, or without
primary and secondary antibody. All controls revealed a complete
absence of labeling as previously documented [8].
Presentation of data and statistical analyses
Quantitative data are presented as mean 6 standard error of
mean (SEM). Statistical comparisons were accomplished by an
unpaired t-test (when variance were the same) or by the Mann-
Whitney rank-sum test (when variances were significantly differ-
ent between groups). P values less than 0.05 were considered as
indicating statistical significance.
RESULTS
Whole animal data
Characterization of the nephrotic syndrome induced by adriamy-
cin. All adriamycin-treated rats developed nephrotic syndrome
with marked proteinuria, hyperlipidemia and ascites (Table 1).
The proteinuria started on day 5 after the injection of adriamycin
and rose to its highest levels on the final day before sacrifice (Day
19, Table 1). The adriamycin-treated rats developed elevated
serum cholesterol and triglyceride levels, cardinal features of the
nephrotic syndrome. The quantity of intraperitoneal fluid (Meth-
ods) in adriamycin-treated rats (5.4 6 3.1 ml) was significantly
greater than in vehicle-treated rats (0.1 6 0.01 ml). Cardiac
weight normalized by body wt (g heart wt/g body wt) was similar
in both groups (adriamycin-treated rats, 0.0033 6 0.0001; control
rats, 0.0037 6 0.0002). Thus, we conclude that the adriamycin-
treated rats had fully-developed nephrotic syndrome with extra-
cellular fluid volume expansion at the time that they were killed
for analysis of renal transporter expression.
Renal function. Table 2 summarizes urinary and serum values in
adriamycin-treated and vehicle-treated rats. Urinary volume and
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osmolality were not significantly different between the two groups.
However, urinary sodium concentration was significantly lower in
the adriamycin-treated animals. Indeed, the rate of urinary so-
dium excretion (not shown in Table 2) was markedly decreased in
adriamycin-nephrotic rats (81.2 nmol/min) compared to the con-
trols (600 nmol/min). Neither serum sodium nor osmolality were
significantly different between the two groups. The clearance of
endogenous creatinine at the end of the experimental period was
not significantly different between the two groups of rats, al-
though the mean was nominally lower in the adriamycin-treated
group (Table 2).
Aquaporin expression
Collecting duct aquaporin expression. Figure 1 shows immuno-
blots comparing aquaporin-2 protein expression levels in ne-
phrotic and control rats. Each lane was loaded with a sample from
a different rat. Equal loading among lanes was confirmed by
Coomassie staining of SDS-PAGE gels run in parallel with the gel
used for immunoblotting. In both cortex and medulla, two bands
were observed as demonstrated previously [8, 9], namely, a sharp
band at 29 kDa due to the presence of nonglycosylated aqua-
porin-2 and a broad band representing the glycosylated form of
the protein. There was a striking decrease in aquaporin-2 expres-
sion in inner medulla in the nephrotic rats (Fig. 1, top), similar to
the observation previously made in rats with PAN-induced ne-
phrotic syndrome [16]. In addition, Figure 1 shows that this effect
was not limited to the medulla, but was also seen in cortex. The
densitometric analysis of these blots is summarized in Table 3. In
the inner medulla, the aquaporin-2 band density for adriamycin-
nephrotic rats averaged 18% of the mean for control rats, whereas
in the cortex a smaller decrease was seen.
Figure 2 shows results from the same animals using the
anti-aquaporin-3 antibody. Two bands were observed as demon-
strated previously [11], a sharp band at 27 kDa representing the
nonglycosylated protein, and a broader, higher molecular weight
band representing the glycosylated protein. As seen with PAN-
induced nephrotic syndrome [16], there was a decrease in aqua-
porin-3 expression in inner medulla of adriamycin-nephrotic rats
(Fig. 2, top). As seen with aquaporin-2, this decrease was not
limited to the inner medulla and, in fact, there was a marked
decrease in aquaporin-3 expression in cortex (Fig. 2, bottom). As
Fig. 1. Immunoblots comparing expression of aquaporin-2 in kidneys of
vehicle-treated control and adriamycin-nephrotic rats. Each lane was
loaded with a sample from a different rat (inner medulla, 1 mg total
protein per lane; cortex, 10 mg total protein per lane). In both regions a
mature band appears at 35 kDa and a nonglycosylated band at 29 kDa. See
Table 3 for densitometric analysis.
Table 1. Characterization of the nephrotic syndrome induced by adriamycin
Urinary protein
excretion
mg/day
Serum protein
g/dl
Serum cholesterol Serum triglycerides Intraperitoneal
fluid mlmg/dl
Vehicle-treated (N 5 6) 10.1 6 2.4 6.3 6 0.6 5.3 6 0.3 5.9 6 0.7 0.10 6 0.01
Adriamycin-treated (N 5 6) 687 6 86a 4.6 6 0.5 48.1 6 4.7a 75.6 6 17.1a 5.4 6 3.1a
Urinary protein excretion was measured on final day before sacrifice. Serum samples were obtained the time of sacrifice. Results are expressed as
mean 6 SEM.
a p , 0.001 vs. control rats.
Table 2. Renal function data
Urinary volume
ml/day
Urine osmolality
mOsm/kg H2O
Urinary sodium Serum sodium
Serum osmolality
mOsm/kg H2O
Creatinine clearance
ml/min/100 g body wtmmol/liter
Vehicle-treated (N 5 6) 5.4 6 0.4 1529 6 163 160.7 6 29.7 140.8 6 0.9 298 6 4 0.40 6 0.04
Adriamycin treated (N 5 6) 5.6 6 1 1101 6 201 20.9 6 5.1a 139.6 6 1.9 298 6 4 0.28 6 0.04
Urinary data was measured on final day before sacrifice. Serum samples were obtained the time of sacrifice. Results are expressed as mean 6 SEM.
a P , 0.05 versus control rats.
Table 3. Densitometric analysis of immunoblots
Inner
Medulla Cortex
Aquaporin-2 18% 6 6%b 48% 6 8%a
Aquaporin-3 18% 6 4%b 33% 6 15%b
Aquaporin-4 7% 6 6%a —
Aquaporin-1 47% 6 15% 22% 6 7%b
Na, K-ATPase a1-subunit 90% 6 8% —
Vasopressin regulated urea transporter 7% 6 0.2%b —
Gsa 25% 6 4%
a —
Adenylyl cyclase VI 12% 6 2%a —
Values represent results in nephrotic rats expressed as a percent of the
mean for vehicle controls. Results are expressed as mean 6 SEM.
a P , 0.05, b P , 0.01 vs. control rats.
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summarized in Table 3, aquaporin-3 band density was decreased
to 18% of control levels in the inner medulla and to 33% of
control levels in the cortex.
Finally, the expression of aquaporin-4, a second water channel
expressed in the basolateral membrane of collecting ducts [18]
was also assessed by immunoblotting. Aquaporin-4 expression is
only detectable in the medulla and there are two bands (31 kDa
and 52 kDa) as previously reported [18]. Inner medullary aqua-
porin-4 expression was significantly decreased in the nephrotic
rats compared to vehicle-injected rats (Fig. 3 and Table 3).
Aquaporin-1 expression. Aquaporin-1 is expressed in the proxi-
mal tubule in the renal cortex and descending limb of Henle’s
loop in the renal medulla [4]. Figure 4 shows aquaporin-1
immunoblots for nephrotic and vehicle-infused control rats. There
are two bands, one at 28 kDa and a second one broad band at
; 35 kDa normally seen for aquaporin-1 in the kidney [10]. In
contrast to the collecting duct water channels, there was no
significant decrease in aquaporin-1 expression in the inner me-
dulla (Fig. 4, top). However, the nephrotic rats displayed a
significant decrease in aquaporin-1 expression in the cortex (Fig.
4, bottom and Table 3). Thus, proximal tubular expression of
aquaporin-1 is affected by the nephrotic state while descending
limb expression is not. The cause of the moderate decrease in
proximal aquaporin-1 expression cannot be ascertained from the
present data. Conceivably, the decrease could be due to atrophy
of some of the proximal tubules due to occlusion by casts.
Expression of solute transporters in inner medulla
Figure 5 (top) shows an immunoblot probed with our antibody
to the vasopressin-regulated urea transporter. This transporter is
responsible for facilitated urea transport across the apical plasma
membrane of inner medullary collecting ducts cells [3]. On this
blot made from a 6% polyacrylamide gel, the major isoform runs
at approximately 83 kDa. As can be seen in Figure 5, the
expression level of the vasopressin-regulated urea transporter was
strikingly decreased in inner medullas from adriamycin-nephrotic
rats compared with vehicle-infused controls. As shown in Table 3,
the band density for the vasopressin-regulated urea transporter
protein was decreased in adriamycin nephrotic rats to 7% of
control levels in the inner medulla. A second band, which runs at
approximately 117 kDa, corresponds to a urea transporter protein
Fig. 2. Immunoblots comparing expression of aquaporin-3 in kidneys of
vehicle-treated control and adriamycin-nephrotic rats. Each lane was
loaded with a sample from a different rat (inner medulla, 5 mg total
protein per lane; cortex, 10 mg total protein per lane). See Table 3 for
densitometric analysis. Membrane samples were from the same rats as
those used for Figure 1.
Fig. 3. Immunoblot comparing expression of aquaporin-4 in inner me-
dullas of vehicle-treated control rats and adriamycin-nephrotic rats. Each
lane was loaded with a sample from a different rat. Ten mg of total protein
was loaded onto each lane. Membranes samples were from the same rats
as those used for Figure 1. See Table 3 for densitometric analysis.
Fig. 4. Immunoblot of aquaporin-1 in inner medulla (3 mg total protein
per lane) and cortex (1 mg total protein per lane) comparing control and
nephrotic rats. Membrane samples were from the same rats as those used
for Figure 1. See Table 3 for densitometric analysis.
Fig. 5. Immunoblots comparing inner medullary expression levels of the
vasopressin-regulated urea transporter (upper panel, 5 mg of total
protein loaded per lane) and the Na,K-ATPase a1 subunit (lower panel,
1 mg of total protein were loaded per lane) from control and nephrotic
rats. Each lane was loaded with a sample from a different rat. Membrane
samples were obtained from the same rats as those used for Figure 1. See
Table 3 for densitometric analysis.
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expressed in the inner medullary collecting duct (IMCD) that is
believed to be a modified form of the vasopressin-regulated urea
transporter, possibly a result of glycosylation at a site upstream
from the primary glycosylation site [21].
Figure 5 (bottom) shows an immunoblot, from the same rats,
probed with a monoclonal antibody to the Na,K-ATPase a1
subunit. The Na,K-ATPase a1 subunit protein in the rat has 1018
amino acids [22] and this antibody recognizes a band at close to
the expected molecular weight for this protein (;100 kDa). In
contrast to the aquaporins and urea transporters, there were no
changes in Na,K-ATPase a1 subunit expression in the inner
medullas of adriamycin-nephrotic rats relative to vehicle-treated
controls. As summarized in Table 3, the band density for Na,K-
ATPase in nephrotic rats was 90% of control in the inner medulla.
Expression of selected regulatory proteins in the inner medulla
Figure 6 shows immunoblots for three regulatory proteins
expressed in the inner medullary collecting duct, viz. the a subunit
of the heterotrimeric G-protein Gs (Gsa), adenylyl cyclase VI and
stress-inducible heat shock protein of 70 kDa (HSP-70), carried
out to determine whether their expression is altered in adriamy-
cin-induced nephrotic syndrome. The anti-Gsa antibody recog-
nizes a doublet at 50 kDa and 45 kDa [19]. There was a significant
decrease in Gsa protein expression in the inner medullas from
nephrotic rats (Fig. 6, top). Band density for adriamycin-nephrotic
rats was decreased to 25% of control levels in the inner medulla
(Table 3).
Figure 6 (middle) shows an immunoblot for type VI adenylyl
cyclase in inner medullas of nephrotic and control rats. Type VI is
the major isoform expressed in collecting duct [23]. In rat, it is a
1180 amino acid integral membrane protein [24] that is presum-
ably glycosylated. The antibody recognizes a broad band around
160 kDa, consistent with the expected size of the protein. As seen
in Figure 6, there was a striking decrease in adenylyl cyclase VI
expression in inner medullas of nephrotic rats relative to controls.
The band density was decreased to 12% of control levels in the
inner medulla (Table 3).
Figure 6 (bottom) shows an immunoblot probed an antibody to
the heat shock protein HSP-70, a protein involved in the cellular
response to various forms of cell stress [25]. In contrast to the
other two signaling proteins examined, there was no significant
change in the expression of the HSP-70 in inner medullas of
nephrotic relative to control rats.
Morphological observations
Figure 7 shows representative electron microscopic views of
medullary collecting ducts from vehicle-treated (Fig. 7A) and
adriamycin-treated rats (Fig. 7B) 17 days following treatment. The
cells lining the medullary collecting ducts of adriamycin-nephrotic
rats are normal in appearance with their normal complement of
intracellular organelles. However, as in our previous study of the
medullary collecting ducts in the PAN model of nephrotic syn-
drome [16], enlarged intercellular spaces are evident. We previ-
ously demonstrated that the enlargement of intercellular spaces
are artifacts resulting from high interstitial pressure during the
perfusion fixation of the kidneys, since they are not seen following
immersion fixation. (Interspace expansion is not seen in vehicle
controls, presumably because collecting duct water permeability is
Fig. 6. Immunoblots of Gsa protein (upper panel, 5 mg of total protein
per lane), adenylyl cyclase type VI (middle panel, 10 mg of total protein
were loaded per lane) and heat shock protein of 70 kD (HSP-70) (lower
panel, 5 mg of total protein were loaded per lane) in inner medullas from
control and nephrotic rats. Each lane was loaded with a sample from a
different rat. Membrane samples were from the same rats as those used
for Figure 1. See Table 3 for densitometric analysis.
Fig. 7. Transmission electron micrographs of inner medullary collecting
ducts. (A) Thin section through inner medullary collecting duct cells from
a vehicle-treated control rat kidney. The cells exhibit relatively straight
intercellular borders, distinct apical junctional complexes (small arrows)
and a paucity of cytoplasmic organelles (N is nucleus. 33,500). (B) Thin
section through inner collecting duct cells from nephrotic rat, seventeen
days following treatment with adriamycin. Other than the presence of
distended intercellular spaces due to perfusion fixation (asterisks), the
collecting duct cells appear normal, that is, similar to inner collecting duct
cells from control rats. The small arrows indicate tight junctions (N is
nucleus. 33,500).
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high enough in the control state to allow a secretory transepithe-
lial water flux to vent the high pressure in the interstitium [16].)
Cellular distribution of aquaporin-2
We carried out differential centrifugation experiments and
immunocytochemistry to assess the distribution of aquaporin-2
within the collecting duct principal cells in nephrotic kidneys, with
a view toward determining whether there is substantial impair-
ment of aquaporin-2 trafficking to the plasma membrane. Figure
8 shows immunoblots from differential centrifugation experi-
ments comparing aquaporin-2 content in the vesicle-enriched
fraction (200,000 3g pellet from 17,000 3 g supernatant) to the
aquaporin-2 content in the plasma membrane-enriched fraction
(17,000 3g pellet). Densitometric analysis of these results dem-
onstrated a statistically significant redistribution of aquaporin-2
(ratio of band density of 17,000 3 g fraction to 200,000 3 g
fraction: control rats, 0.09 6 0.02; adriamycin-nephrotic rats,
0.27 6 0.05; P , 0.01). Thus, in collecting ducts from nephrotic
rats, a greater fraction of the total aquaporin-2 was present in the
plasma-membrane-enriched fraction.
The results from differential centrifugation experiments were
confirmed by immunoperoxidase immunocytochemistry of inner
medullary thin sections (Fig. 9). As expected from the immuno-
blotting results, there was a marked decrease in the intensity of
the aquaporin-2 labeling in inner medullary collecting ducts from
adriamycin-nephrotic rats compared to controls. However, the
residual aquaporin-2 can be seen to be located chiefly in the apical
region of the principal cells, suggesting that trafficking mecha-
nisms that deliver aquaporin-2 to the plasma membrane are
probably intact.
DISCUSSION
In the work presented here, we used the adriamycin model of
nephrotic syndrome to determine whether there is altered expres-
sion of collecting duct water and solute transporters associated
with the nephrotic syndrome. The adriamycin-treated rats devel-
oped heavy proteinuria, marked ascites, and hyperlipidemia,
indicative of development of full-blown nephrotic syndrome. The
immunoblotting results (Figs. 1 to 3) showed a marked decrease in
the expression of all three collecting duct water channels, viz.
aquaporin-2, -3, and -4, in the nephrotic rats. The finding of a
marked suppression of aquaporin-2 and aquaporin-3 expression in
the inner medullary collecting duct is consistent with the results of
our previous study of the nephrotic syndrome in which we used a
different means of inducing the nephrotic state, namely, puromy-
cin aminonucleoside (PAN) injection [16]. These findings suggest
that down-regulation of aquaporin-2 and aquaporin-3 is a feature
of nephrotic syndrome per se rather than being an idiosyncrasy of
any particular model. Possibly the suppression of aquaporin
expression in the collecting ducts of nephrotic animals is an
indirect consequence of the brisk proteinuria seen in both models,
although the cellular mechanisms involved were not investigated
in this study.
It is also conceivable that the down-regulation of aquaporin-2
and aquaporin-3 expression was a result of direct effects of PAN
and adriamycin on collecting duct cells, rather than an effect of
the nephrotic syndrome per se. The mechanism whereby these
agents induce loss of the foot processes of glomerular visceral
epithelial cells is unknown, but presumably involves a loss of
normal targeting of the vesicular traffic involved in maintaining
complex cell shape in these cells. Conceivably, the decline in
aquaporin expression could be a consequence of inefficient tar-
geting in collecting duct cells resulting in increased degradation of
the proteins. Further studies are necessary to address this issue.
To determine if the decrease in expression of aquaporin water
channels is limited to the medullary part of the collecting duct or
may be seen throughout the collecting duct system, immunoblot-
ting was done with cortical samples as well as medullary samples.
As shown in Figures 1 and 2, the decrease in the collecting duct
water channel abundance (aquaporin-2 and -3) in adriamycin-
induced nephrotic syndrome was seen in cortex as well as medulla.
(Because aquaporin-4 is not normally expressed in the cortical
part of the collecting duct in substantial quantities [18], we could
not evaluate whether it is suppressed there.) These observations
therefore suggest that there is a general decrease in aquaporin-2
and aquaporin-3 expression throughout the collecting duct sys-
tem. Thus, these results rule out mechanisms that would be
unique to the inner medulla, such as effect of prostaglandins
elaborated from medullary interstitial cells or effects of changes in
interstitial osmolality.
The present study demonstrates that the suppression of trans-
porter expression is not limited to water channels, but also
includes a solute transporter expressed in the inner medullary
collecting duct, namely the vasopressin-regulated urea trans-
porter. This transporter is important to the urinary concentrating
mechanism because it supplies urea to the inner medullary
interstitium and therefore is responsible for the corticomedullary
urea gradient [26]. Thus, suppression of vasopressin-regulated
urea transporter expression may contribute to the concentrating
defect seen in nephrotic syndrome. Examination of Coomassie-
stained gels of inner medullary proteins (not shown) indicated
that the expression levels of most major proteins in the inner
medulla were unchanged in the adriamycin-nephrotic syndrome
animals relative to controls. Examples of specific proteins whose
expression levels were not suppressed in the inner medullas of
nephrotic rats are the a-1 subunit of Na,K-ATPase (Fig. 5) and
the heat shock protein HSP-70 (Fig. 6). Thus, the down-regulation
of transporter protein expression appears to be relatively selec-
tive. Other pathophysiological states have been demonstrated to
Fig. 8. Immunoblots comparing aquaporin-2 levels in membrane frac-
tions from vehicle-treated control rats versus adriamycin-nephrotic rats.
Upper panel, vesicle-enriched fraction (200,000 3 g pellet, 2 mg protein
per lane). Lower panel, plasma-membrane-enriched fraction (17,000 3 g
pellet, 2 mg protein per lane). Individual lanes were loaded with mem-
brane protein samples from different rats. Rats were the same ones as
those used for Figure 1.
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manifest a down-regulation of aquaporin-2 expression, viz. lithi-
um-induced nephrogenic diabetes insipidus (NDI) [27], hypokal-
emia-induced NDI [28], and ureteral obstruction [29]. We postu-
late that similar or identical mechanisms could be involved in the
down-regulation seen in all of these entities including nephrotic
syndrome. Further studies will be required to address this possi-
bility.
The nephrotic syndrome is characterized by an extracellular
volume expansion due to renal sodium and water retention. The
finding that the collecting duct water transport pathways are
down-regulated is consistently with the generally held view that
the maintenance of water retention is not dependent on increased
water reabsorption in the collecting duct, but rather depends on
increased NaCl absorption along the nephron. Indeed, we spec-
ulate that the down-regulation of aquaporin-2 expression could
represent a physiologically appropriate response to extracellular
volume expansion, perhaps similar to the suppression of aqua-
porin-2 that accounts for the vasopressin-escape phenomenon
[30]. The price that the kidney must pay for this physiologically
appropriate down-regulation would be a decrease in urinary
concentrating and diluting capacity and hence a limitation in the
ability to maintain water balance with extremes of free water
intake. Indeed, both urinary concentration and dilution has been
shown to be reduced in nephrotic syndrome [reviewed in 16].
Presumably, renal salt and water retention in this model of
nephrotic syndrome depends on some combination of increased
NaCl and water reabsorption in earlier segments, and perhaps to
some extent on reduced glomerular filtration rate. In the present
Fig. 9. Immunoperoxidase immunocytochemistry in thin sections from vehicle-treated control and adriamycin-nephrotic rats. (A and C) Aquaporin-2
localization in inner medullary collecting ducts of control rats. Note abundant expression and distribution to both apical plasma membrane (arrows in
C) as well as cytoplasm (arrowheads in C). (B and D) Aquaporin-2 localization in inner medullary collecting ducts of adriamycin-nephrotic rats. Note
the markedly diminished expression level with much of remaining labeling associated with the apical plasma membrane (arrows in D).
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study, although creatinine clearance was not significantly de-
creased in adriamycin nephrotic rats there was a nominal differ-
ence in the mean, suggesting that there may have been some
reduction in glomerular filtration rate not detectable with our
methods.
The down-regulation of collecting duct water and urea trans-
porter expression in the adriamycin-induced nephrotic syndrome
is not a result of disruption of cell integrity or a perceptible
rearrangement of cell architecture (Fig. 7). In the present study,
like in the previous study of PAN-induced nephrotic syndrome,
transporter down-regulation occurred despite the fact that the
collecting duct cells were morphologically normal as demon-
strated both by light microscopy and electron microscopy. This
finding suggests that the down-regulation does not depend on
disruption of normal cell architecture. Furthermore, the collecting
duct did not show any evidence of local obstruction due to casts,
in contrast to what was seen in proximal tubules and distal
nephron segments. Presumably, the lack of obstructive changes in
the collecting duct is owing to the branching architecture of the
collecting duct system.
The chief factor responsible for the regulation of renal water
excretion in the normal state is vasopressin. Circulating vasopres-
sin levels were demonstrated to be increased in PAN-induced
nephrotic syndrome in rats, and are presumably increased in
adriamycin-induced nephrotic syndrome as well. The vasopressin
receptor responsible for the regulation of water permeability in
the collecting duct is the so-called V2 receptor. This receptor is an
integral membrane protein coupled to adenylyl cyclase through
the heterotrimeric G protein Gs. Receptor occupation increases
intracellular cyclic AMP levels in collecting duct cells through
activation adenylyl cyclase [31]. Elevated cyclic AMP levels in-
crease the water permeability of the kidney collecting duct in two
separate ways [2]. “Short-term” regulation occurs as a result of the
ability of cyclic AMP to trigger the fusion of aquaporin-2 contain-
ing intracytoplasmic vesicles with the apical plasma membrane,
resulting in an increase in the number of apical water channels
and consequently an increase in water permeability. “Long-term”
regulation is an adaptive increase in collecting duct water perme-
ability that results from an absolute increase in the number of
aquaporin-2 water channels in collecting duct principal cells. This
response is believed to be in part a result of transcriptional
regulation mediated by phosphorylation of cyclic AMP response
element (CRE)-binding protein (CREB) and binding of phospho-
CREB to a cyclic AMP regulatory element (CRE) in the 59
flanking region of the aquaporin-2 gene [32]. The present study
shows substantial decreases in the expression levels of Gsa and
adenylyl cyclase VI in the inner medulla of adriamycin-induced
nephrotic rats. Such decreases could theoretically result in de-
creases in cellular cyclic AMP levels. Therefore, they raise the
possibility that the demonstrated decrease in aquaporin-2 expres-
sion in the inner medulla of nephrotic rats is a result of chronically
decreased intracellular cAMP levels. This possibility remains
untested presently. There is evidence from the prior studies with
PAN-induced nephrotic syndrome [16] and the present studies
(Figs. 8 and 9) that the nephrotic syndrome is associated with an
activation of the short-term regulation of aquaporin-2 with in-
creased trafficking of aquaporin-2 to the plasma membrane. This
result is seemingly in contradiction with the view that cyclic AMP
levels may be suppressed. However, the short-term regulation of
water permeability is more complex than generally recognized and
may involve regulation of both exocytosis and endocytosis of
aquaporin-2, possibly via multiple signaling pathways [33, 34].
Thus, studies of alterations in both cyclic AMP and non-cyclic
AMP mediated intracellular signaling seem to be warranted in rat
models of nephrotic syndrome.
In summary, adriamycin induced-nephrotic syndrome in rats
has been demonstrated to be associated with a marked reduction
in the expression levels of three aquaporins and the vasopressin-
regulated urea transporter in the collecting duct system. These
decreases in the protein expression appear to be relatively selec-
tive, and are most likely associated with the nephrotic syndrome
per se rather than the drugs used to induce the nephrotic
syndrome. These changes may represent an appropriate kidney
response to the extracellular volume expansion observed in ne-
phrotic syndrome.
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